Pei‐Yi Chu

6.1k total citations
210 papers, 4.7k citations indexed

About

Pei‐Yi Chu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Pei‐Yi Chu has authored 210 papers receiving a total of 4.7k indexed citations (citations by other indexed papers that have themselves been cited), including 119 papers in Molecular Biology, 76 papers in Oncology and 43 papers in Cancer Research. Recurrent topics in Pei‐Yi Chu's work include Epigenetics and DNA Methylation (29 papers), RNA modifications and cancer (23 papers) and Protein Tyrosine Phosphatases (17 papers). Pei‐Yi Chu is often cited by papers focused on Epigenetics and DNA Methylation (29 papers), RNA modifications and cancer (23 papers) and Protein Tyrosine Phosphatases (17 papers). Pei‐Yi Chu collaborates with scholars based in Taiwan, China and United States. Pei‐Yi Chu's co-authors include Chia‐Jung Li, Ming‐Feng Hou, Meng‐Yu Wu, Kuen‐Feng Chen, Hsing‐Ju Wu, Chun‐Yu Liu, Ling‐Ming Tseng, Chung-Wai Shiau, Hung‐Yu Lin and Yao‐Li Chen and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Pei‐Yi Chu

206 papers receiving 4.7k citations

Peers

Countries citing papers authored by Pei‐Yi Chu

Since Specialization

Citations

This map shows the geographic impact of Pei‐Yi Chu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pei‐Yi Chu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pei‐Yi Chu more than expected).

Fields of papers citing papers by Pei‐Yi Chu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Pei‐Yi Chu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pei‐Yi Chu. The network helps show where Pei‐Yi Chu may publish in the future.

Co-authorship network of co-authors of Pei‐Yi Chu

This figure shows the co-authorship network connecting the top 25 collaborators of Pei‐Yi Chu. A scholar is included among the top collaborators of Pei‐Yi Chu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Pei‐Yi Chu. Pei‐Yi Chu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Fractionation and identification of ocular protective compounds from kochiae fructus against oxidative damage in retinal pigment epithelium cells 2025 ·Journal of Ethnopharmacology ·(unknown), Pei‐Yi Chu, (unknown), Ta‐Hsien Chuang, Yingchun Yu, Yicheng Pan, Yi‐Ting Lin, Chih‐Hsin Tang, Chia-Lin Lee, Yang‐Chang Wu	0
2	The potential immunotherapy effect of Ginkgolide B thwarts oral squamous cell carcinoma progression by targeting the SREBP1/KLK8/CCL22 axis 2024 ·Phytomedicine ·(unknown), Pei‐Yi Chu, Meei‐Ling Sheu, (unknown), Yuan‐Hao Lee, Shuchun Liu, Ta‐Chih Liu	3
3	Evaluating the Feasibility of a Deep Learning-Based Atypical Cell Gallery for Clinical Diagnosis in Urine Cytology 2023 ·Journal of the American Society of Cytopathology ·(unknown), (unknown), (unknown), (unknown), (unknown), Hsing‐Ju Wu, Cheng‐Hung Yeh, (unknown), (unknown), Pei‐Yi Chu	1
4	Current and Developing Liquid Biopsy Techniques for Breast Cancer 2022 ·Cancers ·Hsing‐Ju Wu, Pei‐Yi Chu	35
5	A New Biorecognition-Element-Free IDμE Sensor for the Identification and Quantification of E. coli 2022 ·Biosensors ·Yung-Kai Lin, Hsing‐Ju Wu, Nguyễn Văn Hiếu, Pei‐Yi Chu, (unknown), (unknown), (unknown), Congo Tak‐Shing Ching	4
6	Identification of Novel Biomarkers and Candidate Drug in Ovarian Cancer 2021 ·Journal of Personalized Medicine ·Chia‐Jung Li, Li‐Te Lin, Pei‐Yi Chu, An‐Jen Chiang, Hsiao‐Wen Tsai, Yi‐Han Chiu, (unknown), Zhi‐Hong Wen, Kuan‐Hao Tsui	17
7	Expression pattern and prognostic impact of glycoprotein non-metastatic B (GPNMB) in triple-negative breast cancer 2021 ·Scientific Reports ·Yu-Hsiang Huang, Pei‐Yi Chu, Ji‐Lin Chen, Chun‐Teng Huang, (unknown), Yi‐Fang Tsai, Yuling Wang, Pei‐Ju Lien, Ling‐Ming Tseng, Chun‐Yu Liu	20
8	LGR5 overexpression confers poor relapse-free survival in breast cancer patients 2018 ·BMC Cancer ·Ming‐Feng Hou, Po‐Ming Chen, Pei‐Yi Chu	36
9	Predictors of Survival in Esophageal Squamous Cell Carcinoma with Pathologic Major Response after Neoadjuvant Chemoradiation Therapy and Surgery: The Impact of Chemotherapy Protocols 2016 ·BioMed Research International ·Chia-Ying Li, Pei‐Ming Huang, Pei‐Yi Chu, Po‐Ming Chen, Mong‐Wei Lin, Shuenn‐Wen Kuo, Jang‐Ming Lee	9
10	Effects of pulsed-radiofrequency neuromodulation on the rat with overactive bladder 2016 ·Neurourology and Urodynamics ·(unknown), Tsung‐Hsun Hsieh, (unknown), (unknown), (unknown), Chih‐Ting Lin, Shih-Ching Chen, Pei‐Yi Chu, Chih‐Wei Peng, (unknown), (unknown)	6
11	IL‐1β Promotes Malignant Transformation and Tumor Aggressiveness in Oral Cancer 2014 ·Journal of Cellular Physiology ·Chia‐Huei Lee, Jeffrey S. Chang, (unknown), Thian‐Sze Wong, Jimmy Yu‐Wai Chan, (unknown), (unknown), (unknown), Chiung‐Tong Chen, Shao‐Chun Lu, (unknown), (unknown), Pei‐Yi Chu, Jenn‐Ren Hsiao, Ko‐Jiunn Liu	168
12	SC-60, a Dimer-Based Sorafenib Derivative, Shows a Better Anti–Hepatocellular Carcinoma Effect than Sorafenib in a Preclinical Hepatocellular Carcinoma Model 2013 ·Molecular Cancer Therapeutics ·Wei‐Tien Tai, Chung-Wai Shiau, (unknown), Yao-Li Chen, Pei‐Yi Chu, Jui-Wen Huang, (unknown), (unknown), Pei‐Jer Chen, Kuen‐Feng Chen	7
13	Tubulopapillary Carcinoma-A Frequent Over-Diagnosed Entity in Canine Mammary Gland Tumors 2012 ·Pei‐Yi Chu, Chung‐Min Yeh, Kun‐Tu Yeh, Liu Ch	0
14	Clustered DNA methylation changes in polycomb target genes in early-stage liver cancer 2012 ·Biochemical and Biophysical Research Communications ·Yao-Li Chen, (unknown), (unknown), (unknown), Chia‐Chen Hsu, Pei‐Yi Chu, (unknown), (unknown), (unknown), (unknown), (unknown), Tim H-M. Huang, Yu-Wei Leu, (unknown)	13
15	Targeted Methylation of Two Tumor Suppressor Genes Is Sufficient to Transform Mesenchymal Stem Cells into Cancer Stem/Initiating Cells 2011 ·Cancer Research ·(unknown), Pei‐Chi Hou, Kuan‐Der Lee, Pei‐Yi Chu, Kun‐Tu Yeh, Victor X. Jin, Min‐Jen Tseng, Shaw‐Jenq Tsai, Yu‐Sun Chang, Chi‐Sheng Wu, H. Sunny Sun, Kuen‐Daw Tsai, Long‐Bin Jeng, Kenneth P. Nephew, Tim H-M. Huang, Shu‐Huei Hsiao, Yu‐Wei Leu	79
16	Lipomatous apocrine adenoma with syringocystadenoma papilliferum arising from the external auditory canal 2011 ·Head & Neck Oncology ·(unknown), (unknown), (unknown), Pei‐Yi Chu, Meiling Chen	14
17	Borderline clear cell adenofibroma with extensive hemorrhagic necrosis 2010 ·Hematology/Oncology and Stem Cell Therapy ·Jinglan Liu, Pei‐Yi Chu, Kun‐Tu Yeh, (unknown)	5
18	Small Cell Carcinoma of the Uterine Cervix: A Case Report with Emphasis on Cytopathological Findings 2006 ·(unknown), (unknown), Cheng‐Chieh Chen, Chin-Cheng Lee, Pei‐Yi Chu	3
19	Infantile Myofibromatosis of Multiple Bones with Spontaneous Regression-A Case Report 2006 ·Pei‐Yi Chu, (unknown), (unknown), Chin-Cheng Lee	2
20	Chondrosarcoma of the Skull Base-Report of Two Cases 2006 ·Pei‐Yi Chu, (unknown), (unknown), (unknown), Chin-Cheng Lee	3

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact